c-Met/VEGFR2 dual inhibitors (Takeda)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namec-Met/VEGFR2 dual inhibitors (Takeda)
Drug Alias NameT-1840383
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVascular endothelial growth factor receptor 2 antagonistsHepatocyte growth factor receptor inhibitors
TargetsVascular endothelial growth factor receptor 2Hepatocyte growth factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTakeda Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTakeda Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A